BioSpace News Archive

Pharm Country

IO Biotech to Present at Jefferies Global Healthcare Conference

IO Biotech announced today that Mai-Britt Zocca, Ph.D., the company’s President and CEO, will be presenting, and both Dr. Zocca and Amy Sullivan, the company’s CFO, will be participating in one-on-one investor meetings at the Jefferies Global Healthcare Conference to be held June 4-6, 2024 in New York.

May 23, 2024
·
3 min read
Biotech Beach

ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

ChromaDex Corp. today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber, will be participating in the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.

May 23, 2024
·
2 min read
Business

PurMinds NeuroPharma Appoints Vanessa Williamson as Chief Business Officer

PurMinds NeuroPharma (“PurMinds™" or the “Company”), a clinical-stage neuroscience company focused on advancing a robust pipeline of small molecules, psychedelic compounds, and other modalities for the treatment of neurological and neurodegenerative disorders

May 23, 2024
·
3 min read
Business

AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)

AstraZeneca and Alexion, AstraZeneca Rare Disease, will showcase 14 studies, including real-world evidence (RWE), from their portfolio and pipeline of investigational amyloidosis therapies at the International Symposium on Amyloidosis (ISA), in Rochester, MN from May 26–30, 2024.

May 23, 2024
·
13 min read
Genetown

Agenus to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

Agenus Inc. today announced that Dr. Garo Armen, Chairman and CEO, and Robin Taylor, Chief Commercial Officer, will participate in a fireside chat and investor one-on-ones at the upcoming Goldman Sachs Global Healthcare Conference on June 10th – 13th in Miami Beach, Florida.

May 23, 2024
·
1 min read
Deals

Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement

Rakovina Therapeutics Inc. is pleased to announce the undertaking of a non-brokered Private Placement (the “Offering”) for gross proceeds of up to $1.5 million at a purchase price of $0.10 per Unit.

May 23, 2024
·
4 min read
Deals

Soligenix Encourages Stockholders to Vote FOR Reverse Stock Split

Soligenix, Inc. encourages its eligible stockholders to vote “FOR” a Reverse Stock Split.

May 23, 2024
·
8 min read
Lone Star Bio

Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting

Natera, Inc. today announced that the company, along with its collaborators, will present new data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 31 – June 4, 2024.

May 23, 2024
·
6 min read
BioMidwest

Inspire Medical Systems, Inc. to Present at the 2024 Jefferies Global Healthcare Conference

Inspire Medical Systems, Inc. announced that its management team will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024.

May 23, 2024
·
1 min read
Deals

Taro Shareholders Approve Merger with Sun Pharma

Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. announced that the merger agreement between Taro and Sun Pharma was approved by the affirmative vote of Taro shareholders at an Extraordinary General Meeting and an Ordinary Class Meeting on May 22, 2024.

May 23, 2024
·
4 min read